Detalhe da pesquisa
1.
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view.
J Neural Transm (Vienna)
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261034
2.
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.
J Neural Transm (Vienna)
; 2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196001
3.
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson's disease.
J Neural Transm (Vienna)
; 2023 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329350
4.
L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.
J Neural Transm (Vienna)
; 130(11): 1323-1335, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796288
5.
The 'α-synucleinopathy syndicate': multiple system atrophy and Parkinson's disease.
J Neural Transm (Vienna)
; 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227594
6.
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson's disease: clinical and therapeutic considerations.
J Neural Transm (Vienna)
; 130(11): 1451-1462, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603058
7.
The heterogeneity of Parkinson's disease.
J Neural Transm (Vienna)
; 130(6): 827-838, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169935
8.
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease.
J Neural Transm (Vienna)
; 130(5): 627-646, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062012
9.
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.
J Neural Transm (Vienna)
; 130(5): 611-625, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939908
10.
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes.
J Neural Transm (Vienna)
; 129(10): 1257-1270, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852604
11.
Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.
J Neural Transm (Vienna)
; 129(9): 1201-1217, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428925
12.
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's disease.
J Neural Transm (Vienna)
; 129(5-6): 545-555, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364741
13.
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?
Pharmacopsychiatry
; 55(1): 7-15, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079985
14.
Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.
J Neural Transm (Vienna)
; 128(2): 127-169, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624170
15.
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses.
J Neural Transm (Vienna)
; 127(9): 1217-1228, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32725545
16.
The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's disease.
J Neural Transm (Vienna)
; 127(5): 749-754, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318880
17.
Selegiline: a molecule with innovative potential.
J Neural Transm (Vienna)
; 127(5): 831-842, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562557
18.
Creation of a gene expression classifier for predicting Parkinson's disease rate of progression.
J Neural Transm (Vienna)
; 127(5): 755-762, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385576
19.
Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
J Neural Transm (Vienna)
; 127(2): 231-250, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030485
20.
[Structure and efferences of the substantia nigra pars compacta in Parkinson's disease]. / Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom.
Fortschr Neurol Psychiatr
; 88(9): 591-599, 2020 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-32396943